Scopus BioPharma Inc. Quarterly Common Stock, Shares Authorized from Q4 2019 to Q2 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Scopus BioPharma Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2019 to Q2 2023.
  • Scopus BioPharma Inc. Common Stock, Shares Authorized for the quarter ending June 30, 2023 was 50M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 50M 0 0% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 50M 0 0% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 50M 0 0% Dec 31, 2022 10-Q 2023-08-11
Q3 2022 50M 0 0% Sep 30, 2022 10-Q 2022-11-21
Q2 2022 50M 0 0% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 50M 0 0% Mar 31, 2022 10-Q 2022-05-19
Q4 2021 50M 0 0% Dec 31, 2021 10-K 2023-04-14
Q3 2021 50M 0 0% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 50M Jun 30, 2021 10-Q 2021-08-13
Q1 2021 50M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 50M 0 0% Dec 31, 2020 10-K 2022-04-15
Q3 2020 50M Sep 30, 2020 10-Q/A 2021-02-26
Q4 2019 50M Dec 31, 2019 10-K 2021-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.